Search
for
Sort by
Research 241–270 of 1000+
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- Dissolving microneedle array patches containing mesoporous silica nanoparticles of different pore sizes as a tunable sustained release platform
- Atlas of Geriatric Dermatology
- Acne
- General Dermatology
- Reconnecting
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Dermatolojik Problemler ve COVID-19
- Circumferential acute limited exanthematous pustulosis
- Contents
- 4. Bullous/Mucous Membrane
- Hair Loss After Routine Immunizations
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Cutaneous Drug Reaction Case Reports
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Dermatological manifestations of Coronavirus Disease 2019 (COVID-19)
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- AB0698 SYSTEMIC LUPUS ERYTHEMATOSUS OVER 80 YEARS OF AGE: A RETROSPECTIVE COHORT OF VERY LATE-ONSET IN A THIRD LEVEL HOSPITAL
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Combined Ultrasound and Microneedle for Enhanced Transdermal Delivery: Synergistic Mechanisms and Therapeutic Advances
- EFFECTIVENESS OF APPLE CIDER VINEGAR AS A TREATMENT OF SCABIOSIS, MALASSEZIOSIS, COMPLICATED BY OTITIS EXTERNA IN A DOMESTIC CAT
- Grahams Little Piccardi Lausseur Syndrome - A Rare Case Report with Review of Literature
- Alopecia Areata: Features and Psychological Profiles (South American Perspectives)
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Selective follicular targeting by modification of the particle sizes
- Rare and common manifestations of COVID‐19 in children
- The diagnostic algorithm in pre-invasive cervical lesions
- Long COVID and Post-Covid Conditions (PCC) in 2025
- Vaccines, adjuvants and autoimmunity